Delivery Order SPE2DB20D3103-SPE2DB25FQ3V6
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on July 25, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a firm fixed price ceiling value of $5,593.77 and an ultimate completion date of August 15, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on May 6, 2025, for the supply of Calquence 100 mg tablets (60-count package). This firm fixed-price delivery order, valued at $16,781.31, is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for ultimate completion...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency (DLA) Medical Supply Chain on September 8, 2025, for Calquence 100 mg tablets (60-count units). The contract, issued as a firm fixed-price delivery order with a ceiling value of $22,375.12, has an ultimate completion date of September 29, 2025. This award represents a non-set-aside procurement, indicating that...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $55,937.70 on August 21, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract. The order is scheduled for completion by September 12, 2025, and will be performed at the company's Conshohocken facility. This is a non-set-aside award issued by the Defense or Civilian federal agency's Medical Supply Chain...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,593.77 by the Defense Logistics Agency to supply 60 tablets of Calquence 100 mg, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania. The contract, executed on July 28, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,187.56 for Calquence 100 mg tablets (60-count units) on August 11, 2025, with completion targeted for September 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This firm fixed-price delivery order is set to be completed by June 23, 2025, and represents performance from AmerisourceBergen's Conshohocken, Pennsylvania location. The award is issued under a competitive, non-set-aside procurement mechanism, reflecting AmerisourceBergen's established capability as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Calquence 100 mg tablets (60-count package) valued at $11,187.56. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's existing indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $5,593.77. This is a competitive, non-set-aside award to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. The delivery order represents a continuation of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Calquence 100 mg tablets (60-count packages) with a ceiling value of $5,593.77. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3V6Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Calquence 100 mg tablets (60-count units). This firm fixed-price delivery order, valued at $5,593.77, is scheduled for completion by October 9, 2025, with performance to be executed at the contractor's Conshohocken facility. The award represents a non-competitive procurement executed under an existing contract vehicle with the DLA. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The pharmaceutical product being delivered—Calquence, a specialty oncology medication—exemplifies the contractor's role in supplying critical brand-name therapeutics across multiple therapeutic domains to the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/18/25 |